| Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries. | |
| | |
MedLine Citation:
|
PMID: 14604579 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A survey of policymakers and other influential professionals in four southeast Asian countries (Cambodia, Indonesia, Philippines and Vietnam) was conducted to determine policymakers' views on the public health importance of dengue fever and dengue haemorrhagic fever (DHF), the need for a vaccine and the determinants influencing its potential introduction. The survey, which involved face-to-face interviews with policymakers, health programme managers, researchers, opinion leaders and other key informants, revealed an almost uniformly high level of concern about dengue fever/DHF and a high perceived need for a dengue vaccine. Several characteristics of the disease contribute to this high sense of priority, including its geographic spread, occurrence in outbreaks, the recurrent risk of infection each dengue season, its severity and the difficulty in diagnosis and management, its urban predominance, its burden on hospitals, and its economic toll on governments and families. Research felt to be key to future decision-making regarding dengue vaccine introduction include: disease surveillance studies, in-country vaccine trials or pilot projects, and studies on the economic burden of dengue and the cost-effectiveness of dengue vaccines. The results suggest favourable conditions for public and private sector markets for dengue vaccines and the need for creative financing strategies to ensure their accessibility to poor children in dengue-endemic countries. |
| | |
Authors:
|
Denise DeRoeck; Jacqueline Deen; John D Clemens |
Related Documents
:
|
6151039 - Vaccine prophylaxis of abattoir-associated q fever. 759059 - Reye syndrome associated with vaccination with live virus vaccines. an exploration of p... 1089389 - Changes in the lymphocyte cytoplasmic refractive index following typhoid vaccination. 15329719 - A middle jurassic 'sphenosuchian' from china and the origin of the crocodylian skull. 16650649 - Postexposure protection against marburg haemorrhagic fever with recombinant vesicular s... 3142019 - Extraction of protective components of rickettsia rickettsii with n-octyl-beta-d-glucop... 17267589 - Cellular immunity in adolescents and adults following acellular pertussis vaccine admin... 7887759 - Enhancing physician adoption of practice guidelines. dissemination of influenza vaccina... 21154139 - Biological therapeutics research and development--gtcbio's fifth annual conference. oct... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Vaccine Volume: 22 ISSN: 0264-410X ISO Abbreviation: Vaccine Publication Date: 2003 Dec |
Date Detail:
|
Created Date: 2003-11-07 Completed Date: 2004-04-08 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8406899 Medline TA: Vaccine Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 121-9 Citation Subset: IM |
Affiliation:
|
International Vaccine Institute, P.O. Box 14, Kwanak, 151-600 Seoul, South Korea. denise_deroeck@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Asia, Southeastern
/
epidemiology Cost-Benefit Analysis Data Collection Dengue / epidemiology, mortality, prevention & control* Health Policy* Hospitalization Humans Immunization Programs / economics, legislation & jurisprudence Infection Control Practitioners Public Health Research Rural Population Urban Population Viral Vaccines* / economics |
| Chemical | |
Reg. No./Substance:
|
0/Viral Vaccines |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: European Sero-Epidemiology Network: standardisation of the assay results for pertussis.
Next Document: Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic...